Hexamethyldisilazane lithium salt 1M in THF, 20%, 25ml

Dietilamina, mínimo 99,5 %, para síntesis, 500 ml, envase de vidrio

1-Benzyl-4-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)piperazine, 98+%, 250mg

3-Amino-5-(4-chlorophenyl)thiophene-2-carboxamide, 250mg

N-[(5-Chloro-3-oxido-1H-benzotriazol-1-yl)-4-morpholinylmethylene]-N-methylmethanaminium hexafluorophosphate, 98%, 5g

3-(Trifluoromethyl)-1H-pyrazolo[3,4-b]pyridine, 95.0%, 10g

4-Bromo-2-(difluoromethyl)thiazole, 98%, 250mg

3-(3-Fluorophenyl)-2,2-dimethylpropanoic acid, 250mg

tert-Butyl 2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)acetate, 95.0%, 5g

Matraces aforados con tapón de vidrio, clase A Vidrio transparente, 50 ml, 14/23, 2 Unidad(es)

3-Chloro-2-fluoro-4-(methylthio)pyridine, 98%, 5g

3,4-Dihydroxy-5-methoxybenzaldehyde, 95.0%, 10g

1-(ETHYLAMINO)-3-(4-(2-METHOXYETHYL)PHENOXY)PROPAN-2-OL, 95.0%, 1g